From: Overexpression of synuclein-γ predicts lack of benefit from radiotherapy for breast cancer patients
Characteristics | Radiotherapy | No Radiotherapy | ||||||
---|---|---|---|---|---|---|---|---|
SNCG- | SNCG+ | χ 2 | p-value | SNCG- | SNCG+ | χ 2 | p-value | |
Age | 0.088 | 0.767 | 0.188 | 0.665 | ||||
<50 years | 21 | 16 | 43 | 33 | ||||
≥50 years | 27 | 18 | 48 | 32 | ||||
Tumor size | 2.126 | 0.145 | 2.161 | 0.142 | ||||
<2 cm | 29 | 15 | 40 | 21 | ||||
≥2 cm | 19 | 19 | 51 | 44 | ||||
Metastasis lymph node | 4.393a | 0.117 | 2.202 | 0.332 | ||||
0 | 19 | 7 | 34 | 17 | ||||
1–3 | 6 | 3 | 31 | 27 | ||||
≥4 | 23 | 24 | 26 | 21 | ||||
TNM stage | 0.628 | 0.428 | 0.003a | 0.957 | ||||
I | 12 | 6 | 7 | 4 | ||||
II, III | 36 | 28 | 84 | 61 | ||||
ER | 1.058 | 0.304 | 0.001 | 0.998 | ||||
negative | 12 | 13 | 34 | 25 | ||||
positive | 32 | 21 | 53 | 39 | ||||
PR | 1.874 | 0.171 | 0.014 | 0.904 | ||||
negative | 23 | 23 | 44 | 33 | ||||
positive | 21 | 11 | 43 | 31 | ||||
HER2 | 0.871 | 0.351 | 0.211 | 0.646 | ||||
negative | 28 | 21 | 50 | 41 | ||||
positive | 7 | 9 | 14 | 14 |